BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 138064)

  • 1. Plasminogen and plasmin.
    Robbins KC; Summaria L
    Methods Enzymol; 1976; 45():257-73. PubMed ID: 138064
    [No Abstract]   [Full Text] [Related]  

  • 2. Rabbit plasminogen and plasmin isozymes.
    Castellino FJ; Sodetz JM
    Methods Enzymol; 1976; 45():273-86. PubMed ID: 138065
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the active center of human plasmin. The serine and histidine residues.
    Groskopf WR; Hsieh B; Summaria L; Robbins KC
    J Biol Chem; 1969 Jan; 244(2):359-65. PubMed ID: 4237580
    [No Abstract]   [Full Text] [Related]  

  • 4. The mechanism of activation of rabbit plasminogen by urokinase. Lack of a preactivation peptide.
    Sodetz JM; Brockway WJ; Mann KG; Castellino FJ
    Biochem Biophys Res Commun; 1974 Sep; 60(2):729-36. PubMed ID: 4278813
    [No Abstract]   [Full Text] [Related]  

  • 5. Bovine factor X 1a (activated Stuart factor). Evidence of homology with mammalian serine proteases.
    Titani K; Hermodson MA; Fujikawa K; Ericsson LH; Walsh KA; Neurath H; Davie EW
    Biochemistry; 1972 Dec; 11(26):4899-903. PubMed ID: 4264286
    [No Abstract]   [Full Text] [Related]  

  • 6. The primary structure of human plasminogen. I. The NH 2 -terminal sequences of human plasminogen and the S-carboxymethyl heavy (A) and light (B) chain derivatives of plasmin.
    Robbins KC; Bernabe P; Arzadon L; Summaria L
    J Biol Chem; 1972 Nov; 247(21):6757-62. PubMed ID: 4263615
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound.
    Wiman B; Wallén P
    Eur J Biochem; 1973 Jul; 36(1):25-31. PubMed ID: 4270055
    [No Abstract]   [Full Text] [Related]  

  • 8. NH2-terminal sequences of mammalian plasminogens and plasmin S-carboxymethyl heavy (A) and light (B) chain derivatives. A re-evaluation of the mechanism of activation of plasminogen.
    Robbins KC; Bernabe P; Arzadon L; Summaria L
    J Biol Chem; 1973 Oct; 248(20):7242-6. PubMed ID: 4270330
    [No Abstract]   [Full Text] [Related]  

  • 9. Radioimmunoassay of human plasminogen and plasmin.
    Rabiner SF; Goldfine ID; Hart A; Summaria L; Robbins KC
    J Lab Clin Med; 1969 Aug; 74(2):265-73. PubMed ID: 4240543
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiplicity of rabbit plasminogen. Physical characterization.
    Sodetz JM; Brockway WJ; Castellino FJ
    Biochemistry; 1972 Nov; 11(24):4451-8. PubMed ID: 4653125
    [No Abstract]   [Full Text] [Related]  

  • 11. On the primary structure of human plasminogen and plasmin. Purification and characterization of cyanogen-bromide fragments.
    Wiman B; Wallén P
    Eur J Biochem; 1975 Sep; 57(2):387-94. PubMed ID: 126158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation and inhibition of fibrinolysis.
    Castellino FJ; Schick LA; Brockway WJ; Sodetz JM
    Adv Exp Med Biol; 1975; 63():233-43. PubMed ID: 128278
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional Kunitz inhibitor binding domain in plasmin-derived light chain as shown by affinity chromatography.
    Chauvet J; Chabbat J; Acher R
    Int J Pept Protein Res; 1986 Jul; 28(1):85-90. PubMed ID: 2944852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen.
    Wallén P; Wiman B
    Biochim Biophys Acta; 1972 Jan; 257(1):122-34. PubMed ID: 4257942
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: On the primary structure of human plasminogen and plasmin, cyanogen bromide fragments.
    Wiman B; Wallén P
    Thromb Diath Haemorrh; 1975 Sep; 34(1):350. PubMed ID: 127402
    [No Abstract]   [Full Text] [Related]  

  • 16. Streptokinase-dependent delayed activation of horse plasminogen.
    Marcum JA; Highsmith RF; Kline DL
    Biochim Biophys Acta; 1982 Dec; 709(1):19-27. PubMed ID: 6217838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional plasminogen in full term newborn--study of active site of plasmin.
    Benavent A; Estellés A; Aznar J; Martinez-Sales V; Gilabert J; Fornas E
    Thromb Haemost; 1984 Feb; 51(1):67-70. PubMed ID: 6232730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the isolation of the multiple molecular forms of human plasminogen and plasmin by isoelectric focusing methods.
    Summaria L; Arzadon L; Bernabe P; Robbins KC
    J Biol Chem; 1972 Jul; 247(14):4691-702. PubMed ID: 4261400
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasminogen-plasmin system IX. Specific binding of tranexamic acid to plasmin.
    Iwamoto M
    Thromb Diath Haemorrh; 1975 Jun; 33(3):573-85. PubMed ID: 125463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breaching the conformational integrity of the catalytic triad of the serine protease plasmin: localized disruption of a side chain of His-603 strongly inhibits the amidolytic activity of human plasmin.
    Mhashilkar AM; Viswanatha T; Chibber BA; Castellino FJ
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5374-7. PubMed ID: 8506386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.